Found: 6
Select item for more details and to access through your institution.
Prevalence of Gabapentinoid and Opioid Copositives in a Reference Laboratory Patient Population.
- Published in:
- Journal of Applied Laboratory Medicine, 2024, v. 9, n. 4, p. 861, doi. 10.1093/jalm/jfae011
- By:
- Publication type:
- Article
Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value.
- Published in:
- Journal of Applied Laboratory Medicine, 2020, v. 5, n. 5, p. 858, doi. 10.1093/jalm/jfaa119
- By:
- Publication type:
- Article
How Can Routine Clinical Laboratories Keep Up with the Opioid Crisis?
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 2, p. 338, doi. 10.1093/clinchem/hvaa305
- By:
- Publication type:
- Article
Circulating microRNA as a biomarker of human growth hormone administration to patients.
- Published in:
- Drug Testing & Analysis, 2014, v. 6, n. 3, p. 234, doi. 10.1002/dta.1469
- By:
- Publication type:
- Article
A population study of urine glycerol concentrations in elite athletes competing in North America.
- Published in:
- Drug Testing & Analysis, 2013, v. 5, n. 11/12, p. 890, doi. 10.1002/dta.1537
- By:
- Publication type:
- Article
Interference in a Glucose Dehydrogenase-Based Glucose Meter.
- Published in:
- Clinical Chemistry, 2010, v. 56, n. 6, p. 1038, doi. 10.1373/clinchem.2010.143453
- By:
- Publication type:
- Article